Cas:26215-90-7 tridecan-4-one manufacturer & supplier

We serve Chemical Name:tridecan-4-one CAS:26215-90-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

tridecan-4-one

Chemical Name:tridecan-4-one
CAS.NO:26215-90-7
Synonyms:MFCD00027351;EINECS 247-519-0;n-Nonyl n-propyl ketone;4-tridecanone
Molecular Formula:C13H26O
Molecular Weight:198.34500
HS Code:2914190090

Physical and Chemical Properties:
Melting point:18-19ºC
Boiling point:260.7ºC at 760mmHg
Density:0.825g/cm3
Index of Refraction:1.431
PSA:17.07000
Exact Mass:198.19800
LogP:4.49630

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like MFCD00027351 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-tridecanone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00027351 Use and application,EINECS 247-519-0 technical grade,usp/ep/jp grade.


Related News: The StartScore model was developed by the company��s in-house supply chain experts based on actual performance data. tridecan-4-one manufacturer Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: ��Within the top 20 global companies that spent the most on R&D in 2018, the top spender �C despite having the second smallest annual revenue of the group at $15.28 billion �C is Celgene, whose R&D spend was equal to 37% of its annual revenue. tridecan-4-one supplier It wasn’t known if this was due to racial differences in breast cancer-related genetic mutations, making it unclear whether race should help guide genetic testing. tridecan-4-one vendor Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: ��Within the top 20 global companies that spent the most on R&D in 2018, the top spender �C despite having the second smallest annual revenue of the group at $15.28 billion �C is Celgene, whose R&D spend was equal to 37% of its annual revenue. tridecan-4-one factory It wasn’t known if this was due to racial differences in breast cancer-related genetic mutations, making it unclear whether race should help guide genetic testing.